Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Hendler

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
The British Journal of Ophthalmology|July 3, 2009
Ruthenium-106 plaque brachytherapy for thick posterior uveal melanomasN Kaiserman, I Kaiserman, K Hendler, et al.
The British Journal of Ophthalmology|February 28, 2008
Intravitreal methotrexate for treating vitreoretinal lymphoma: 10 years of experienceS Frenkel, K Hendler, T Siegal, et al.
The British Journal of Ophthalmology|May 12, 2009
Long-term survival of uveal melanoma patients after surgery for liver metastasesS Frenkel, I Nir, K Hendler, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
The British Journal of Ophthalmology|July 3, 2009
Ruthenium-106 plaque brachytherapy for thick posterior uveal melanomasN Kaiserman, I Kaiserman, K Hendler, et al.
The British Journal of Ophthalmology|February 28, 2008
Intravitreal methotrexate for treating vitreoretinal lymphoma: 10 years of experienceS Frenkel, K Hendler, T Siegal, et al.
The British Journal of Ophthalmology|May 12, 2009
Long-term survival of uveal melanoma patients after surgery for liver metastasesS Frenkel, I Nir, K Hendler, et al.
Pageof 1